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Bone Morphogenetic Protein 5 Regulates the Number
of Keratinocyte Stem Cells from the Skin of Mice
Thaned Kangsamaksin1 and Rebecca J. Morris2,3
Understanding keratinocyte stem cell regulation is important in understanding the pathogenesis of wound
healing and nonmelanoma skin cancer. We previously used a sensitive and quantitative assay for in vitro
keratinocyte colony formation and mapped the keratinocyte stem cell locus (Ksc1) on mouse chromosome 9.
Examination of the candidate genes in this locus disclosed a sequence variant in the gene for bone
morphogenetic protein 5 (Bmp5). In this report, we used a naturally occurring mouse with a null mutation in
this gene to probe stem cell properties in mouse epidermis. We found that the mutant keratinocytes had a
significant reduction in the size and number of clonogenic keratinocytes. The mutant mice had a 50% reduction
in the number of label-retaining cells when compared with their littermates. Addition of exogenous Bmp5
protein increased the number and size of keratinocyte colonies in the mutant as well as their wild-type
littermates. Surprisingly, the mutant mice showed at least a 2-fold increase in skin tumor susceptibility over
their littermates. We conclude that a naturally occurring mutation in Bmp5 affects keratinocyte stem cell
proliferation, and skin tumor susceptibility, and is a candidate stem cell regulatory gene in the Ksc1 locus.
Journal of Investigative Dermatology (2011) 131, 580–585; doi:10.1038/jid.2010.378; published online 23 December 2010
INTRODUCTION
The cutaneous epithelium is a continually renewing tissue
that harbors stem cells responsible for differentiation into the
lineages of the epidermis under normal condition and in
response to wounding. In addition, the behavior of epidermal
stem cells (ESCs) has been shown to be associated with a
variety of skin diseases including skin tumors.
Some stem cells from mouse skin can be distinguished
according to their slowly cycling behavior in vivo and their
ability to form colonies in vitro. Mouse epidermal cells in
the basal layer are organized into morphologically defined
epidermal proliferative units (Potten, 1983). Epidermal whole
mounts of the mouse back skin showed a population ofB10
basal cells and a hexagonal suprabasal group of maturing,
flattened cells. Several laboratories have demonstrated that
there is at least one slowly cycling basal cell in the cluster
of 3 to 4 basal cells in the central column of suprabasal
cells (Bickenbach, 1981; Mackenzie and Bickenbach, 1985;
Morris et al., 1985; Potten, 1986). Cotsarelis et al. (1990)
found that ESCs also resided in the bulge portion of the outer
root sheath in both mouse and human hair follicles.
Interestingly, this finding is also supported by evidence that
epidermal cells from the mouse hair follicles are capable of
regenerating the epidermis following irradiation (reviewed
by Potten, 1986), and they are also capable of regenerating
differentiated hair follicles, sebaceous glands, and interfolli-
cular epidermis even after repeated abrasions (Argyris, 1985).
In addition, the proliferative characteristic of epidermal
cells can be observed in in vitro colony assays that
demonstrated that colonies from adult mouse epidermal
cells at low densities have an extensive growth potential and
can generate a large number of cells that are defined as
holoclones (Barrandon and Green, 1987). The number of
mouse epidermal cell colonies remains essentially constant
throughout most of the adult life as well as following
carcinogenic initiation; however, it varies among different
strains of mice (Morris et al., 1988; Popova et al., 2002).
Our laboratory has shown that the number of epidermal
cell colonies is in fact a genetically definable quantitative
trait (Popova et al., 2002). To identify genes or factors that
regulate stem cell number, a genome-wide linkage analysis
with colonies as a phenotype was performed, and several loci
showed significant linkage in the propensity to form either
larger colonies or smaller colonies (Popova et al., 2003).
Through sequencing analysis of the open reading frames in
the keratinocyte stem cell locus 1 (Ksc1) locus on chromo-
some 9 that showed the most significant linkage, we detected
a variant in the bone morphogenetic protein 5 (Bmp5) gene
(Popova et al., in preparation).
Bone morphogenetic proteins are members of the trans-
forming growth factor-b family that has a role in proliferation,
apoptosis, and differentiation in various tissues and organs
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including skin (Hogan, 1996). Therefore, we chose Bmp5 as a
candidate gene potentially regulating ESC number for further
analysis. We found a naturally occurring mouse mutation in
the Bmp5 gene and we report here that the short-ear mouse,
previously characterized for its cartilage and skeletal anoma-
lies by Kingsley et al. (1992) and King et al. (1994), has
a previously unreported skin stem cell phenotype including
a 2-fold increase in skin tumor susceptibility.
RESULTS
Bmp5 is expressed in the interfollicular epidermis and the hair
follicles of the wild-type mice
To assess Bmp5 expression patterns, we performed immuno-
histochemical analysis of Bmp5 on skin sections from all
genotypes including wild-type C57BL/6 and BALB/c as low
and high controls. As shown in Figure 1, Bmp5 is strongly
expressed in the hair follicles, particularly in the hair follicle
bulge, and in the interfollicular epidermis in both C57BL/6
and BALB/c mice, the parental strains used for mapping. It
seems that Bmp5 is distinctly less expressed in the BALB/c
epidermis than that of C57BL/6. However, it has been
reported that other bone morphogenetic proteins such as
Bmp2 and Bmp4, which are important in the regulation
of hair regeneration, showed periodic expression patterns
(Plikus et al., 2008). Therefore, our data suggest that C57BL/6
and BALB/c may undergo different cyclic regeneration of the
hair follicles, and thus showed different levels of Bmp5
expression at 8 weeks of age. The Bmp5 short-ear mice have
essentially no immunoreactivity to the Bmp5 antibody when
compared with the wild-type littermates, which is consistent
with the null mutation in these mice.
The short-ear mutant mouse shows a decrease
in the number and size of ESC colonies
In Figure 2, we compared the number of colonies between
C57BL/6, BALB/c, and all genotypes of the short-ear mutant
mice. After 2 weeks of culture, the average number of
colonies from BALB/c mice is B64% of that from C57BL/c
mice (Figure 2b). In addition, the average size of the colonies
from BALB/c is B36% smaller than that from C57BL/6. We
observed no difference in the average numbers of colonies
from wild-type and heterozygous groups. However, the short-
ear homozygous mouse showed a significant (28%) decrease
in colony number. The results indicated that only one copy of
functional Bmp5 is sufficient for its function in stem cell
number regulation. In addition to a marked reduction in
colony number, we also observed that the short-ear mutants
also have a reduction in colony size (Figure 2c).
The short-ear mutant mouse shows a decrease in
label-retaining cells (LRCs)
To support the results from colony assays, we also performed
label-retention analyses. It is known that LRCs are located in
the interfollicular epidermis and bulge region of the hair
follicle and are characterized as an important population of
ESCs; thus, we decided to investigate whether the mutant
mice had different numbers of LRCs than their congenic
littermates. At 8 weeks after BrdU labeling, the dorsal skin
was collected and analyzed for BrdU-label retention. As
shown in Figure 3a–e, we observed that there were
significantly fewer LRCs in BALB/c than C57BL/6 and in the
mutant mice than the wild-type littermates. However, the
general location of LRCs, and the size and number of the hair
follicles, remain the same among all genotypes.
Exogenously added human recombinant BMP5 protein
increases the number and size of stem cell colonies in vitro
To demonstrate further the functional significance of Bmp5
on ESC colony formation in vitro, we treated primary
epidermal cells from C57BL/6 and C57BL/6.Cg-Bmp5se/J
heterozygous and homozygous littermates cultured on
irradiated 3T3 feeder layers with recombinant human BMP5
(rhBMP5). After 2 weeks of culture, the average number of
colonies increased in all groups of mice at both low and high
doses of rhBMP5 (Figure 4). As we expected, the homozygous
mutant mice showed fewer colonies than the wild type, and
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Figure 1. Localization of bone morphogenetic protein 5 (Bmp5) in mouse
hair follicles and interfollicular epidermis of wild-type but not mutant mouse
skin. Adult mouse skin was collected for paraffin-embedded histological
sections for (a) C57BL/6, (b) BALB/c, (c) wild-type, and (d) homozygous short-
ear mutant mice at B7 to 8 weeks of age, and BMP5 immunohistochemistry
was performed. B, hair follicle bulge; D, dermis; E, epidermis; HF, hair
follicle; SG, sebaceous gland. Note the intense staining in the hair follicle and
in an occasional interfollicular cell of the wild-type epithelium. In the
homozygous short-ear mutant skin, Bmp5 staining was consistently absent
from hair follicles and interfollicular epidermis. Scale bars¼ 30mm.
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the number of colonies increased in the presence of rhBMP5
to the colony number of the wild-type mouse at as low as
0.01 mgml–1 concentration. Moreover, the average area of
colonies increased with the treatment of rhBMP5 in a similar
trend. These results suggest that Bmp5 might have a role in
regulating the colony number of keratinocyte stem cells.
Bmp5 mutant mice have an increased susceptibility to skin
tumors compared with congenic littermates
Figure 5 demonstrates the increased tumor susceptibility of
the short-ear mutant mice (together with the sequence-
variant-bearing BALB/c mice) when compared with the
heterozygous and congenic littermates. The segregation of
tumor number and tumor latency between the mutant and
wild-type controls was present from 8 weeks of promotion
and continued throughout the experiment. Additionally, the
tumor incidence was virtually 100% in all groups of mice.
There was an increase in the number of tumors in the short-
ear mutant mice; however, we observed that the tumor size
was invariable across all genotypes. As shown in Figure 5a,
although the difference in tumor number was statistically
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Figure 3. Quantification of label-retaining cells (LRCs) in mouse epidermis.
(a–d) Immunohistographs for LRCs are shown. Mice received twice-daily
(1000 and 1700 hours) subcutaneous injections of 50 mg per g body weight of
BrdU at postnatal days D3, D4, and D5. After 8–10 weeks, dorsal skins were
collected and fixed with 10% formalin for at least 24 hours. Cells retaining the
label are identified as LRCs. (e) The bar graph shows the quantification of
labeled cells in the interfollicular epidermis and hair follicles combined.
Labeled cells were counted in the same region of the dorsal skin for every 500
cells. Mean±SD. *P-value o0.05. N¼3. Scale bars¼30 mm.
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Figure 2. Quantification of mouse keratinocyte colonies. Keratinocytes were
isolated from 7- to 8-week-old mice. (a) The photographs of the colony assays
in 60-mm dishes are shown. The (b) number and (c) size of mouse
keratinocyte colonies from all genotypes were quantified after 2 weeks of
cultivation on irradiated 3T3 fibroblasts as a feeder layer. Note that the
number of colonies is significantly less in the homozygous short-ear mutant
mice, whereas colony number and size were relatively greater in the
heterozygous and wild-type congenic littermates. Average number of
colonies±SD. *P-value o0.003, N¼ 3.
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significant, the error bars appeared large when compared
with the few numbers of tumors after 12-O-tetradecanoyl-
phorbol-13-acetate (TPA) treatment, which is commonly the
case for tumor-resistant C57BL/6 background. Figure 5b
showed the average number per mouse versus weeks after
TPA treatment. The mice began to develop tumors after 6–8
weeks.
DISCUSSION
We previously performed linkage analysis and identified the
Ksc1 locus on chromosome 9 as one of the regions that
regulate the small-size phenotype of clonogenic stem cells
(Popova et al., 2004). This observation has led to a hypothesis
that the genes that regulate the size and number of
clonogenic stem cells might also be involved in skin
carcinogenesis. Psl1 (promotion susceptibility locus 1)
represents one of the loci previously shown to be associated
with resistance or susceptibility to two-stage skin carcinogen-
esis, and it is overlapped with the Ksc1 locus (Angel et al.,
1997). In addition, D9Mit271 has been linked to skin tumor
susceptibility (Mock et al., 1998), and Skts6 (skin tumor
susceptibility locus 6) has been recently mapped on the
mouse chromosome 9 (49 cM) (Nagase et al., 1995). These
loci are also closely related to the Ksc1 locus. Therefore,
genes located in the Ksc1 locus regulating the number of
small keratinocyte colonies may also regulate susceptibility
or resistance to two-stage skin carcinogenesis.
Although our use of the naturally occurring mutation in
Bmp5 clearly demonstrates its role in skin stem cell
regulation, there may be another gene in the locus. Popova
et al. (2003) calculated that skin stem cell number was
probably regulated by more than once gene acting together
but possibly inherited independently (Popova et al., 2004).
From our data, Bmp5 appears to act differently that other
Bmps such as Bmp2, Bmp4, and Bmp6. Bmp2 and Bmp6
were described to inhibit keratinocyte growth and prolifera-
tion and induce terminal differentiation in vitro (Gosselet
et al., 2007). It would probably be informative to determine
whether other Bmps have similar effects of in vitro and
in vivo aspects of skin stem cell number as reported in this
study. Additionally, it would be interesting to see whether the
BALB/c sequence variant could be rescued with Bmp5.
BMP signaling has been shown to be necessary for
maintaining quiescence of adult ESCs in the niche, as Smad1
is phosphorylated and Bmp6 levels are elevated in the hair
bulge. Additionally, disruption of BMP signaling through
bmpr1a ablation seems to increase expression of the
transcription factors known to be important for bulge and
progenitor cell maintenance and proliferation, Sox9, Lhx2,
and Shh (Kobielak et al., 2006). Thus, it is likely that BMP
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Figure 4. Exogenous recombinant human bone morphogenetic protein 5
(BMP5) increases keratinocyte colony size and number. (a) To determine the
functional significance of Bmp5 on keratinocyte colony formation, we treated
wild-type and short-ear keratinocytes cultured on 3T3 feeder layers with
different concentrations of recombinant human BMP5 (0.01 and 0.1mgml–1).
The recombinant peptide was added to the medium that was changed every
other day up to 2 weeks of culture. Note that exogenous BMP5 added to
culture increased the number and size of colonies in keratinocytes from all
three genotypes. (b) The photographs of the colony assays each correspond to
the bar graph directly above. Average number of colonies±SD. *P-value
o0.05. N¼ 3.
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Figure 5. Bone morphogenetic protein 5 (Bmp5) regulates the number of
tumors in mice in the two-stage skin carcinogenesis model. (a) The bar
graphs represent the average number of skin tumor across all genotypes.
Mouse skin was initiated with 200 nmol of 7,12-dimethylbenz[a]anthracene
(DMBA) in 200ml of spectral grade acetone when the mice were 7 weeks of
age. After 1 week, there was twice-weekly promotion with 17 nmol of
12-O-tetradecanoylphorbol-13-acetate (TPA) in 200 ml of acetone. Skin
tumors were counted weekly for 20 weeks. Note that Bmp5 status was
associated with the number of skin tumors, with short-ear mutant and
BALB/c mice developing more skin tumors than heterozygous and
wild-type littermates, or C57BL/6J wild-type mice. Wild-type C57BL/6
and BALB/c mice were used, respectively, as low- and high- tumor controls.
(b) The marked-line chart shows the appearance of tumors across all
genotypes. Mean±SD. *P-value o0.05. N¼ 5.
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signaling acts through other pathways in regulating ESC
quiescence and proliferation.
In addition, the BMP signaling pathway was implicated in
the initiation of colorectal neoplasia when mutations in
BMPR1A were found in patients with juvenile polyposis
(Howe et al., 1998). BMP6 has been shown to be absent in
benign prostatic hyperplasia but strongly evident in primary
tumors with secondary skeletal metastases, suggesting that
BMP signaling may promote migration and invasion of
prostate cancer cells (Darby et al., 2008). The role of BMP
signaling in invasiveness and metastasis of cancer cells is not,
to our knowledge, previously unreported, as BMPs and
SMADs have been shown to regulate epithelial–mesenchymal
transition during embryonic development and morphogenesis
(Thiery and Sleeman, 2006).
In our future plans, we would like to investigate
keratinocyte cell proliferation and migration especially in
the ESC population, which can be sorted by CD34 and a6
integrin. We would also like to explore further the nature of
skin tumor development in the short-ear mutant including
development of squamous cell carcinomas and metastasis,
which will require a longer period of TPA treatment and
tumor promotion. Additionally, a recently described Bmp5
dominant negative ‘‘cauliflower ear’’ mouse would be
interesting with regard to skin stem cell regulation and tumor
promotion (Giggey et al., 2005).
Furthermore, our laboratory has had a longstanding
hypothesis that skin stem cells are the target cells in skin
tumorigenesis (Morris et al., 1988; Kangsamaksin et al.,
2007), and hence it is significant that a candidate keratino-
cyte stem cell regulatory gene should also be a skin tumor
susceptibility gene. Nevertheless, the mechanisms through
which this occurs remain to be identified.
MATERIALS AND METHODS
Mice and epidermal cell isolation
All mice were obtained from the Jackson Laboratory (Bar Harbor,
MN): C57BL/6J, BALB/cJ, and C57BL/6.Cg-Bmp5se/J. Columbia
University Institutional Animal Care and Use Committee approved
all animal protocols. Epidermal cells from all groups from the dorsal
skin of 50- to 60-day-old female mice were harvested following
previously described protocols (Morris et al., 1990). The hair follicles
were in the telogen stage during this time that was confirmed by
histological sections. BMP5 polyclonal antibody was purchased
from BioVision (Mountain View, CA; cat. no. 5675-100) and was
used in 1:50 dilutions. Biotinylated secondary antibody was used
(Vector Laboratories, Burlingam, CA) in a 1:100 dilution. The slides
were washed and incubated in ABC alkaline phosphatase/substrate
solutions (Vector Laboratories).
Cell culture
Swiss 3T3 fibroblasts obtained at the 119th passage from American
Type Culture Collection (Rockville, MD) were irradiated with 50Gy
(5,000 rads) and used as feeder cells. Epidermal cells harvested from
each group were placed in 60-mm dishes (1,000 viable cells per
dish) and were cultivated for 2 weeks in Supplemented Williams
medium (Morris et al., 1990). The medium was changed three times
weekly, beginning the second day after seeding. After 2 weeks of
cultivation, dishes were rinsed twice with Dulbecco’s phosphate-
buffered saline and were fixed in 10% formalin for at least 24 hours.
All dishes were stained with Rhodamine B. Epidermal cell colonies
were stained with a higher density than feeder cells, and colonies
40.5mm were counted.
Label-retention analysis
To identify slowly cycling cells, mice received twice-daily (1000 and
1700hours) subcutaneous injections of 50 mg per g body weight of
BrdU (Sigma-Aldrich, St Louis, MO, cat. no. 858,811) at postnatal
days D3, D4, and D5. After 8–10 weeks, dorsal skins were collected
and fixed with 10% formalin for at least 24 hours. Cells retaining the
label are identified as LRCs. Paraffin-embedded skin sections were
rehydrated in a series of ethanol solutions and antigen-retrieved in
2N HCl at 37 1C for 30minutes and 0.1% trypsin for 15minutes. The
slides were then incubated with the rat primary antibody (Accurate
Chemical and Scientific, Westbury, NY; cat. no. OBT0030) in a
1:200 dilution, overnight at 4 1C, followed by washing and
subsequent incubation in biotinylated secondary antibody (Vector
Laboratories) in a 1:100 dilution. The slides were washed and
incubated in ABC alkaline phosphatase/substrate solutions (Vector
Laboratories).
Skin carcinogenesis experiments
Skin tumors were initiated with 200 nmol of DMBA (7,12-
dimethylbenz[a]anthracene) in 200ml of spectral grade acetone
when the mice were 7 weeks of age. After 1 week, there was twice-
weekly promotion with 17 nmol TPA in 200 ml of acetone. Skin
tumors were counted weekly for 20 weeks. Wild-type C57BL/6 and
BALB/c mice were used, respectively, as low and high tumor
controls. Additionally, the short-ear congenic and heterozygous
mice were used as additional controls.
Statistical analysis
Student’s t-test in Excel was performed for each experiment. Each
experiment, except skin carcinogenesis and LRCs, was performed at
least three times.
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